Sign In
Buy PCRX
$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Pacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
11:30am, Wednesday, 13'th May 2020
PARSIPPANY, N.J., May 13, 2020 -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 RBC Capital Markets Global Healthcare Virtual.
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q1 2020 Results - Earnings Call Transcript
09:07am, Monday, 11'th May 2020
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2020 Results Earnings Conference Call May 07, 2020, 08:30 AM ET Company Participants Susan Mesco - Head of Investor Re
Stifel Maintains Hold on Pacira BioSciences, Lowers Price Target to $48
05:41pm, Friday, 08'th May 2020SVB Leerink Maintains Outperform on Pacira BioSciences, Raises Price Target to $45
10:31am, Friday, 08'th May 2020Pacira's (PCRX) Q1 Earnings Top Estimates, Revenues Rise Y/Y
12:00am, Friday, 08'th May 2020Pacira BioSciences Q1 EPS $0.530 Beats $0.320 Estimate, Sales $105.684M Beat $102.970M Estimate
12:27pm, Thursday, 07'th May 2020Pacira BioSciences Q1 EPS $0.530 Beats $0.320 Estimate, Sales $105.700M Beat $102.970M Estimate
12:05pm, Thursday, 07'th May 2020Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update
12:00pm, Thursday, 07'th May 2020
-- Total revenues increased 16 percent over prior year first quarter ---- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020 -- Pacira BioSciences, Inc..
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer
12:00am, Tuesday, 05'th May 2020
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the appointment of Andrew D. Jones as Chief Financial Officer and Treasurer, effective M
Pacira BioSciences Appoints Donald C. Manning, M.D., Ph.D. as Chief Medical Officer
11:30am, Monday, 04'th May 2020
Pacira BioSciences, Inc. (PCRX), a leading provider of innovative non-opioid pain management options, today announces the appointment of Donald C. Manning, M.D., Ph.D., as the Company’s Chief Medica
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Q1 2020 Earnings Estimate for Pacira Biosciences Inc Issued By Wedbush (NASDAQ:PCRX)
05:14am, Friday, 01'st May 2020
Pacira Biosciences Inc (NASDAQ:PCRX) – Equities researchers at Wedbush cut their Q1 2020 earnings per share (EPS) estimates for Pacira Biosciences in a research note issued to investors on Monday, A
Viking Therapeutics (VKTX) Gets a Buy Rating from Stifel Nicolaus
12:26am, Friday, 01'st May 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Viking Therapeutics (VKTX), with a price target of $14.00.
Viking Therapeutics (VKTX) Gets a Buy Rating from Stifel Nicolaus
12:26am, Friday, 01'st May 2020
In a report released yesterday,
Derek Archila
from Stifel Nicolaus reiterated a
Buy
rating on Viking Therapeutics (
VKTX
–
Research Report
), with a price target of
$14.00
. The company’s shares c
